CHD5 was frequently mutated in stomach adenocarcinoma (7%) and UCEC (14%) (Figure 1B), whereas CHD7 mutations were identified in 8% of CRC cases (Figure 1B, Table S5). The gene discussed is CHD5; the disease is gastric adenocarcinoma.